Edoxaban for stroke prevention in Chinese patients with atrial fibrillation: 1-year follow-up of the ETNA-AF-China study

In a large Chinese AF population, edoxaban showed low incidences of stroke and bleeding, notably major bleeding, ICH, major gastrointestinal bleeding, and CV mortalities, with the majority of patients still on edoxaban at the end of 1-year follow-up.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-01-22
DOI
https://doi.org/10.3389/fphar.2026.1739246
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Edoxaban for stroke prevention in Chinese patients with atrial fibrillation: 1-year follow-up of the ETNA-AF-China study

Jieyun Liu, Hui Feng, JUNYOU CUI, Xiaojun Ji et al.
Frontiers in Pharmacology
Atrial Fibrillation Management and Outcomes
article

Edoxaban for stroke prevention in Chinese patients with atrial fibrillation: 1-year follow-up of the ETNA-AF-China study

Jieyun Liu, Hui Feng, JUNYOU CUI, Xiaojun Ji, Martin Unverdorben, Bing Deng, Lun Li, Xiang Cheng, Juan Du, Juan Ma, Xiaojun Ji, Yi Yuan, Hui Qi, Zheng Huang, Jingfeng Wang, Xue Liang, Yongqi Xiao, Cangsang Song, Cathy Chen, Suxin Luo, Changsheng Ma
article en

Abstract

In a large Chinese AF population, edoxaban showed low incidences of stroke and bleeding, notably major bleeding, ICH, major gastrointestinal bleeding, and CV mortalities, with the majority of patients still on edoxaban at the end of 1-year follow-up.

Frontiers in PharmacologyVol. 17
Sun Yat-sen University (CN), Shanxi Medical University (CN), Daiichi Sankyo (Germany) (DE), Capital Medical University (CN), Dalian Medical University (CN), Wuhan Puai Hospital (CN), Sun Yat-sen Memorial Hospital (CN), Second Affiliated Hospital of Chongqing Medical University (CN), First Affiliated Hospital of Guangzhou Medical University (CN), Shanghai University of Traditional Chinese Medicine (CN), Wenzhou Central Hospital (CN), Daiichi Sankyo (United Kingdom) (GB), Longhua Hospital Shanghai University of Traditional Chinese Medicine (CN), Jiangyin People's Hospital (CN), The First Hospital of Changsha (CN), Fifth Affiliated Hospital of Zhengzhou University (CN), The First Hospital of Kunming (CN), Beijing Anzhen Hospital (CN), Daiichi Sankyo (India) (IN), Wuhan Union Hospital (CN), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), Taiyuan Central Hospital (CN), Daiichi-Sankyo (South Korea) (KR), Riverside Hospital of Guangxi Zhuang Autonomous Region (CN), First People's Hospital of Nanning (CN), Union Hospital (US), Nanjing Jiangning Hospital (CN), Daiichi Sankyo (United States) (US), Union Hospital (CN), Huazhong University of Science and Technology (CN), Chongqing Medical University (CN), Guangzhou Medical University (CN)
Good health and well-being
Openalex Percentile: Top 82%
Atrial Fibrillation Management and Outcomes
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.